December 19, 2017 | David Kohn
Contact
Office of Public Affairs
655 West Baltimore Street
Bressler Research Building 14-002
Baltimore, Maryland 21201-1559
Contact Media Relations
(410) 706-5260
Related stories
Wednesday, July 19, 2023
New Innovation in CAR T-Cells Paves Way for Less Toxic Therapy Against Multiple Myeloma
University of Maryland School of Medicine (UMSOM) researchers engineered a new type of CAR T-cell therapy that, in preclinical studies, selectively attacked cancer cells while sparing healthy cells, potentially reducing the likelihood of toxic side effects from this innovative cancer treatment. The cells were designed specifically to attack multiple myeloma, a cancer of the plasma cells found in the body’s bone marrow.
Wednesday, April 05, 2023
Understanding E. Coli Strains That Do Not Cause Diarrhea Could Lead to New Treatments
News reports featuring E. coli often tell terrifying stories of intestinal illness and diarrhea or deadly outbreaks from contaminated food. There are, however, many different strains of the bacteria E. coli, or Escherichia coli, and not all are bad.
Friday, July 29, 2022
Why Breast-Fed Premature Infants Have A Healthier Gut Than Formula-Fed Ones
Human breastmilk has long been considered “liquid gold” among clinicians treating premature infants in a newborn intensive care unit (NICU). Breastmilk-fed “preemies” are healthier, on average, than those fed formula. Why is that true, however, has remained a mystery.
Monday, September 20, 2021
UM School of Medicine Receives $7.5 Million Grant to Create Complex Model of Female Reproductive Tract to Study Infections
Researchers at the Institute for Genome Sciences (IGS) at the University of Maryland School of Medicine have received a $7.5 million federal grant to create a complex model of the female reproductive system in order to study sexually transmitted infections (STIs). They plan to create a realistic 3D model that integrates vaginal and cervical epithelial cells and the bacteria that colonize these cells, called a microbiome. They aim to use this model to identity factors that play a role in chlamydia and gonorrhea infections experienced by a growing number of women in the U.S. and worldwide.
Friday, October 18, 2019
Diabetes Worsens Respiratory Illness Due to Abnormal Immune Response, UM School of Medicine Study Finds
Since the Middle East respiratory syndrome coronavirus (MERS-CoV) first emerged in Saudi Arabia in 2012, there have been more than 2,400 confirmed cases of the infection, resulting in greater than 800 deaths – an alarming fatality rate of 35 percent. For this reason, researchers have been eager to identify any risk factors that contribute to the development of severe or lethal disease. Current clinical evidence points to diabetes as a major risk factor in addition to other comorbidities including kidney disease, heart disease, and lung disease.
Tuesday, August 13, 2019
Researchers Identify How Vaginal Microbiome Can Elicit Resistance or Susceptibility to Chlamydia
The vaginal microbiome is believed to protect women against Chlamydia trachomatis, the etiological agent of the most prevalent sexually transmitted infections (STIs) in developed countries. New research by the University of Maryland School of Medicine (UMSOM) shows how the microbiome can either protect or make a woman more susceptible to these serious infections.
Friday, September 14, 2018
Nationwide Research on African-American Kidneys Hopes to Unravel Genetic Variation That Increases Disease Risk
With African-Americans developing kidney failure at rates four to five times higher than Americans of European descent, a groundbreaking nationwide study will track nearly every African-American donor kidney over the next five years.
Thursday, March 22, 2018
With Big Data, Researchers Identify New Targets for Lung Disease Treatments
Every year, approximately 12 million adults in the U.S. are diagnosed with Chronic Obstructive Pulmonary Disease (COPD), and 120,000 die from it. For people with COPD, Haemophilus influenzae, a bacterium, can be particularly dangerous.